Sleep Apnea and Cognition in Older Adults
Cross-sectional Investigation of Sleep Apnea and Cognition in Older Adults Using the ANNE Vital Sign System
1 other identifier
observational
300
1 country
1
Brief Summary
The goal of this cross-sectional, observational, medical device trial is to examine the association of several sleep parameters, including specific respiratory events and an apnea-hypopnea index, with cognitive performance in older adults. The main question the study aims to answer is: Is there an association between sleep parameters with cognitive performance? Researchers will collect sleep parameters from participants using a device called the ANNE Vital Sign System and will test whether they are associated with performance on different memory and thinking tasks. Participants will: Complete a battery of cognitive tests to assess their memory and thinking performance. Wear the ANNE Vital Sign System continuously for a period of 24 hours.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 9, 2024
CompletedFirst Submitted
Initial submission to the registry
May 15, 2024
CompletedFirst Posted
Study publicly available on registry
May 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2034
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2034
May 21, 2024
April 1, 2024
10 years
May 15, 2024
May 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Association between apnea-hypopnea index and cognitive performance
An apnea-hypopnea index, the combined average number of apneas and hypopneas that occur per hour of sleep, will be calculated from ANNE Vital Sign System data. Study staff will annotate apneas and hypopneas to calculate the index using an EEG annotation tool. A linear regression model will be constructed to examine the association between apnea-hypopnea index and performance on a battery of neuropsychological tests, which includes: 1. Montreal Cognitive Assessment 2. Free and Cued Selective Reminding Test 3. Benson Complex Figure Copy 4. Doors Test, Parts A and B 5. WAIS-III Symbol Digit Coding 6. Benson Complex Figure Delay 7. Benson Complex Figure Recognition 8. 7-24 Spatial Recall Test 9. Colour Trails Test, parts 1 and 2 10. Controlled Oral Word Association Test (FAS) 11. Semantic Fluency (Animals) 12. Trail Making Test, parts A and B
24 hours
Study Arms (1)
Healthy Older Adults
* Age 55-85 * 8+ years of education * No frank cognitive impairment or dementia
Interventions
The ANNE Vital Sign System is a pair of non-invasive, flexible sensors originally designed for vital signs monitoring in the paediatric intensive care unit.
Eligibility Criteria
Healthy older adults between the ages of 55-85, with 8+ years of education and no frank cognitive impairment or dementia.
You may qualify if:
- Sufficient knowledge of English to understand and provide informed consent
- Competent to provide consent
- Aged 55-85, Male and Female
- ≥ 8 years of education
- Capable of cooperating for the duration of the study procedures and assessments
- No frank cognitive impairment or dementia
- Sufficient (corrected) vision to participate in cognitive testing
- Sufficient (corrected) hearing to participate in cognitive testing
You may not qualify if:
- Cannot read and comprehend English language instructions
- Major cardio- or cerebro-vascular event (heart attack, stroke, significant white matter changes)
- Unstable diseases (e.g., pulmonary, endocrine disorder)
- Active malignancy or infectious diseases
- History of significant learning disability
- Major psychiatric/neurologic/degenerative disorder, including a diagnosis of mild cognitive impairment or dementia
- History of significant head trauma or recurrent concussions requiring hospitalization followed by persistent neurologic defaults or known structural brain abnormalities
- Pain or sleep disorder that could interfere with cognitive testing
- Major medical concerns that might interfere with cognitive testing
- Recent history of substance/drug abuse
- Known nickel allergy
- Known cardiac implantable device
- Known arrhythmias
- Outside the included age range
- Pregnant or breast feeding
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sunnybrook Health Sciences Centrelead
- Alzheimer Society of Canadacollaborator
Study Sites (1)
Sunnybrook Health Sciences Centre
Toronto, Ontario, M6G3T6, Canada
Related Publications (7)
Foley DJ, Monjan AA, Brown SL, Simonsick EM, Wallace RB, Blazer DG. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep. 1995 Jul;18(6):425-32. doi: 10.1093/sleep/18.6.425.
PMID: 7481413BACKGROUNDSenaratna CV, Perret JL, Lodge CJ, Lowe AJ, Campbell BE, Matheson MC, Hamilton GS, Dharmage SC. Prevalence of obstructive sleep apnea in the general population: A systematic review. Sleep Med Rev. 2017 Aug;34:70-81. doi: 10.1016/j.smrv.2016.07.002. Epub 2016 Jul 18.
PMID: 27568340BACKGROUNDOosterman JM, van Someren EJ, Vogels RL, Van Harten B, Scherder EJ. Fragmentation of the rest-activity rhythm correlates with age-related cognitive deficits. J Sleep Res. 2009 Mar;18(1):129-35. doi: 10.1111/j.1365-2869.2008.00704.x.
PMID: 19250179BACKGROUNDShi L, Chen SJ, Ma MY, Bao YP, Han Y, Wang YM, Shi J, Vitiello MV, Lu L. Sleep disturbances increase the risk of dementia: A systematic review and meta-analysis. Sleep Med Rev. 2018 Aug;40:4-16. doi: 10.1016/j.smrv.2017.06.010. Epub 2017 Jul 6.
PMID: 28890168BACKGROUNDSindi S, Kareholt I, Johansson L, Skoog J, Sjoberg L, Wang HX, Johansson B, Fratiglioni L, Soininen H, Solomon A, Skoog I, Kivipelto M. Sleep disturbances and dementia risk: A multicenter study. Alzheimers Dement. 2018 Oct;14(10):1235-1242. doi: 10.1016/j.jalz.2018.05.012. Epub 2018 Jul 17.
PMID: 30030112BACKGROUNDZhu X, Zhao Y. Sleep-disordered breathing and the risk of cognitive decline: a meta-analysis of 19,940 participants. Sleep Breath. 2018 Mar;22(1):165-173. doi: 10.1007/s11325-017-1562-x. Epub 2017 Sep 13.
PMID: 28905231BACKGROUNDChung HU, Kim BH, Lee JY, Lee J, Xie Z, Ibler EM, Lee K, Banks A, Jeong JY, Kim J, Ogle C, Grande D, Yu Y, Jang H, Assem P, Ryu D, Kwak JW, Namkoong M, Park JB, Lee Y, Kim DH, Ryu A, Jeong J, You K, Ji B, Liu Z, Huo Q, Feng X, Deng Y, Xu Y, Jang KI, Kim J, Zhang Y, Ghaffari R, Rand CM, Schau M, Hamvas A, Weese-Mayer DE, Huang Y, Lee SM, Lee CH, Shanbhag NR, Paller AS, Xu S, Rogers JA. Binodal, wireless epidermal electronic systems with in-sensor analytics for neonatal intensive care. Science. 2019 Mar 1;363(6430):eaau0780. doi: 10.1126/science.aau0780.
PMID: 30819934BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Rabin, PhD
Sunnybrook Research Institute
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Scientist
Study Record Dates
First Submitted
May 15, 2024
First Posted
May 21, 2024
Study Start
April 9, 2024
Primary Completion (Estimated)
April 1, 2034
Study Completion (Estimated)
April 1, 2034
Last Updated
May 21, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share